ProShare Advisors’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.9K | Sell |
|
|||||
|
2025
Q1 | $19.6K | Sell |
|
|||||
|
2024
Q4 | $43.2K | Buy |
|
|||||
|
2024
Q3 | $28.9K | Buy |
|
|||||
|
2024
Q2 | $36.6K | Sell |
|
|||||
|
2024
Q1 | $63.7K | Buy |
|
|||||
|
2023
Q4 | $78.7K | Buy |
|
|||||
|
2023
Q3 | $71.6K | Buy |
|
|||||
|
2023
Q2 | $76.2K | Buy |
|
|||||
|
2023
Q1 | $108K | Sell |
|
|||||
|
2022
Q4 | $141K | Buy |
|
|||||
|
2022
Q3 | $158K | Buy |
|
|||||
|
2022
Q2 | $117K | Sell |
|
|||||
|
2022
Q1 | $289K | Sell |
|
|||||
|
2021
Q4 | $432K | Buy |
|
|||||
|
2021
Q3 | $421K | Sell |
|
|||||
|
2021
Q2 | $444K | Buy |
|
|||||
|
2021
Q1 | $404K | Buy |
|
|||||
|
2020
Q4 | $441K | Buy |
|
|||||
|
2020
Q3 | $362K | Sell |
|
|||||
|
2020
Q2 | $361K | Buy |
|
|||||
|
2020
Q1 | $216K | Sell |
|
|||||
|
2019
Q4 | $426K | Sell |
|
|||||
|
2019
Q3 | $525K | Buy |
|
|||||
|
2019
Q2 | $569K | Sell |
|
|||||
|
2019
Q1 | $398K | Buy |
|
|||||
|
2018
Q4 | $258K | Sell |
|
|||||
|
2018
Q3 | $561K | Sell |
|
|||||
|
2018
Q2 | $481K | Buy |
|
|||||
|
2018
Q1 | $362K | Sell |
|
|||||
|
2017
Q4 | $325K | Buy |
|
|||||
|
2017
Q3 | $471K | Buy |
|
|||||
|
2017
Q2 | $426K | Sell |
|
|||||
|
2017
Q1 | $659K | Sell |
|
|||||
|
2016
Q4 | $945K | Buy |
|
|||||
|
2016
Q3 | $826K | Sell |
|
|||||
|
2016
Q2 | $553K | Buy |
|
|||||
|
2016
Q1 | $676K | Sell |
|
|||||
|
2015
Q4 | $797K | Buy |
|